Table 2.
Baseline patient characteristics (n=30)
| Variables | n (%) |
|---|---|
| Age, median (range) | 75 (70-84) |
| Gender (female:male) | 10:20 |
| ECOG-PS | |
| 0 | 11 (37) |
| 1 | 19 (63) |
| Cancer type | |
| non-small-cell lung cancer | 24 (80) |
| Pancreatic cancer | 6 (20) |
| Stage | |
| III | 3 (10) |
| IV or postoperative recurrence | 27 (90) |
| Treatment | |
| Cytotoxic regimen | 20 (67) |
| Targeted regimen | 10 (33) |
| Comorbidities | |
| Chronic lung disease | 13 (43) |
| Type 2 diabetes | 9 (30) |
| Cardiovascular disease | 7 (23) |
| Double cancer | 3 (10) |
| Cerebrovascular disease | 1 (3) |
| Lifestyle | |
| Living alone | 4 (14) |
| Unemployed | 18 (62) |
| No exercise habit | 16 (53) |
| History of falls in prior 1 month | 3 (10) |
| Frequency of going out (≤2 days a week) | 4 (13) |
| No participation in house chores | 5 (17) |
| Nutritional status | |
| Percentage weight change in the past 6 months (mean±SD) | −3.0±6.8 |
| Cancer cachexia* | 12 (40) |
| Skeletal muscle depletion† | 21 (70) |
*Diagnosis was based on the international consensus criteria, †Skeletal muscle depletion was defined as lumbar skeletal muscle mass index of <43.0 cm2/m2 for men with a BMI <25.0 kg/m2, <53.0 cm2/m2 for men with a BMI ≥25.0, and <41.0 cm2/m2 in women. ECOG-PS: Eastern Cooperative Oncology Group Performance Status, SD: Standard deviation, BMI: Body mass index